Henry Schein, Inc. (HSIC)
Company Description
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.
It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins.
The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners.
This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services.
Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
| Country | United States |
| Founded | 1932 |
| IPO Date | Nov 3, 1995 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 22,000 |
| CEO | Stanley M. Bergman |
Contact Details
Address: 135 Duryea Rd Melville, New York 11747 United States | |
| Phone | (631) 843-5500 |
| Website | henryschein.com |
Stock Details
| Ticker Symbol | HSIC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001000228 |
| CUSIP Number | 806407102 |
| ISIN Number | US8064071025 |
| Employer ID | 11-3136595 |
| SIC Code | 5047 |
Key Executives
| Name | Position |
|---|---|
| Stanley M. Bergman | Executive Chairman and Chief Executive Officer |
| James P. Breslawski | Executive Vice Chairman and Pres |
| Steven Paladino | Executive Director |
| Mark E. Mlotek | Executive Vice President, Chief Strategic Officer and Exec. Director |
| Ronald N. South | Senior Vice President and Chief Financial Officer |
| Michael Saul Ettinger | Executive Vice President and Chief Operating Officer |
| Olga Timoshkina | Vice President of Corporate Finance, Chief Accounting Officer and Corp. Controller |
| Christopher Pendergast | Senior Vice President and Chief Technology Officer |
| Graham Stanley | Vice President of Investor Relations and Strategic Finance Project Officer |
| Walter Siegel | Senior Vice President and Chief Legal Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 7, 2023 | 10-Q | Quarterly Report |
| Aug 7, 2023 | 8-K | Current Report |
| Jul 13, 2023 | 8-K | Current Report |
| Jun 23, 2023 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 12, 2023 | 144 | Filing |
| Jun 5, 2023 | 144 | Filing |
| Jun 2, 2023 | 144 | Filing |
| May 25, 2023 | 8-K | Current Report |
| May 25, 2023 | SD | Form - SD |
| May 24, 2023 | 144 | Filing |